Alan Lafley - Procter Gamble Executive Chairman and Member of Proxy Committee

PG Stock  MXN 2,605  15.92  0.61%   

Chairman

Mr. Alan G. Lafley is no longer Executive Chairman of the Board of the Company. effective June 30 2016. He was Chairman of the Board President Chief Executive Officer of The Procter Gamble Company. Mr. Lafley originally joined the Company in 1977 and held positions of increasing responsibility in the U.S. and internationally until he was elected President and Chief Executive Officer in 2000 a position he held until June 30 2009. On July 1 2002 Mr. Lafley was elected Chairman of the Board a position he held until January 2010. During the past five years in addition to his roles as a Company employee Mr. Lafley served as a consultant to the Company and as a member of the boards of directors of public companies Dell Inc. and General Electric Company. He no longer serves on these boards. Since his retirement from the Company he served as a Senior Advisor at Clayton Dubilier Rice LLC a private equity partnership and was appointed by President Obama to serve on The Presidents Council on Jobs and Competitiveness. Mr. Lafley consulted with a number of Fortune 50 companies on business and innovation strategy. He also advised on CEO succession and executive leadership development and coached experienced new and potential CEOs. He currently serves on the board of directors of Legendary Pictures LLC . since 2015.
Age 67
Tenure 9 years
Phone513 983 1100
Webhttps://www.pginvestor.com

Procter Gamble Management Efficiency

The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3202 %, meaning that it generated $0.3202 on every $100 dollars invested by stockholders. Procter Gamble's management efficiency ratios could be used to measure how well Procter Gamble manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 22.85 B in total debt with debt to equity ratio (D/E) of 0.7, which is about average as compared to similar companies. Procter Gamble has a current ratio of 0.69, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Procter Gamble until it has trouble settling it off, either with new capital or with free cash flow. So, Procter Gamble's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Procter Gamble sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Procter to invest in growth at high rates of return. When we think about Procter Gamble's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records

CHAIRMAN Age

German VelascoGMxico Transportes SAB
66
Roy BostockDelta Air Lines
73
Francis BlakeDelta Air Lines
69
Oscar RochaGMxico Transportes SAB
85
David DormanCVS Health
64
Hector NavarroGrupo Sports World
Thomas KingsburyBurlington Stores
65
Michael LawrieDXC Technology
64
Daniel CarpDelta Air Lines
70
German VelascoSouthern Copper
66
Luis SanchezHoteles City Express
59
The Procter Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. PROCTER GAMBLE operates under Household Personal Products classification in Mexico and is traded on Mexico Stock Exchange. It employs 101000 people. The Procter Gamble (PG) is traded on Mexican Exchange in Mexico and employs 106,000 people.

Management Performance

Procter Gamble Leadership Team

Elected by the shareholders, the Procter Gamble's board of directors comprises two types of representatives: Procter Gamble inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Procter. The board's role is to monitor Procter Gamble's management team and ensure that shareholders' interests are well served. Procter Gamble's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Procter Gamble's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathleen Fish, Chief Research, Development and Innovation Officer
Craig Buchholz, Chief Communications Officer and Vice President – Communications, Personal Health Care and Oral Care
Matthew Janzaruk, VP Officer
Mary FergusonMcHugh, Group President - Global Family Care and Global Brand Creation and Innovation, P&G Ventures
Kenneth Chenault, Independent Director
Debra Lee, Independent Director
Mindy Sherwood, President Global Walmart
Amy Chang, Independent Director
Nelson Peltz, Independent Director
Martin Riant, Group Pres and Advisor to the CEO
Hatsunori Kiriyama, President - Asia
Magesvaran Suranjan, President - Asia Pacific Selling and Market Operations
Kirti Singh, Chief Analytics and Insights Officer
Tarek Farahat, President - Latin America
Francis Blake, Independent Director
Thomas Finn, President - Personal Health Care
Mohamed Samir, President - India, Middle East and Africa
Alexandra Keith, President - Global Hair Care and Beauty Sector
Susan DesmondHellmann, Independent Director
Valarie Sheppard, Controller and Treasurer and Executive Vice President - Company Transition Leader
Fama Francisco, Chief Executive Officer - Baby and Feminine Care
Loic Tassel, President - Europe
Margaret Whitman, Independent Director
Walter McNerney, Lead Independent Director
Terry Lundgren, Independent Director
Shelly McNamara, Senior Vice President of Human Resources
Angela Braly, Independent Director
Giovanni Ciserani, Group President of Global Fabric and Home Care and Global Baby and Feminine Care
M Grabowski, Chief Human Resource Officer
Javier Polit, Chief Information Officer
B Allen, Independent Director
James McNerney, Lead Independent Director
Ernesto Zedillo, Independent Director
Steven Bishop, Chief Executive Officer - Health Care
Scott Cook, Independent Director
Henry Karamanoukian, President Go-to-Market, China and Hair Care, Greater China
Sundar Raman, President - Fabric Care, North America and P&G Professional, Global
Ernesto Leon, Independent Director
Susan Whaley, Chief Sec
R Keith, Chief Executive Officer - Beauty
Yannis Skoufalos, Global Product Supply Officer
Linda ClementHolmes, CIO
Jennifer Davis, President - Feminine Care
John Chevalier, Director - Investor Relations
Juan Posada, President - Latin America Selling and Market Operations
Fatima Francisco, Feminine Baby
Alan Lafley, Executive Chairman and Member of Proxy Committee
Jeffrey Schomburger, Global Sales Officer
Monica Turner, Senior Vice President - Sales, North America
Vittorio Cretella, Chief Information Officer
Christine McCarthy, Independent Director
Patricia Woertz, Independent Director
Shailesh Jejurikar, Chief Executive Officer - Fabric and Home Care
Philip Duncan, Chief Design Officer
Andre Schulten, Chief Officer
Marc Pritchard, Global Brand Building Officer
Markus Strobel, President - Skin & Personal Care
David Taylor, Chairman of the Board, President, Chief Executive Officer
Mark Biegger, Global Human Resources Officer
Joseph Jimenez, Independent Director
Matthew Price, President - Greater China Selling and Market Operations
Julio Nemeth, President - Global Business Services
Laura Becker, President - Global Business Services
Deborah Majoras, Chief Legal Officer, Secretary
Jon Moeller, Vice Chairman of the Board, Chief Financial Officer
Charles Pierce, Group President - Global Grooming
Gary Coombe, President - Europe Selling and Market Operations
Carolyn Tastad, Group President - North America and Chief Sales Officer
Ken Patel, Chief Counsel

Procter Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Procter Gamble a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Procter Gamble using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in The Procter Gamble. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Procter Stock please use our How to Invest in Procter Gamble guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for Procter Stock analysis

When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.